METCrusaders
@metcrusaders
Multi-stakeholder biomarker group for MET exon 14 skipping (cap; tep); MET amplification; or MET overexpression (Teliso-V). Pan-tumor. [email protected]
@metcrusaders hasn’t posted
When they do, their posts will show up here.